These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8972106)

  • 1. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
    Watanabe KH; Bois FY
    Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
    Bois FY; Woodruff TJ; Spear RC
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzene toxicokinetics in humans: exposure of bone marrow to metabolites.
    Watanabe KH; Bois FY; Daisey JM; Auslander DM; Spear RC
    Occup Environ Med; 1994 Jun; 51(6):414-20. PubMed ID: 8044234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.
    Bois FY; Paxman DG
    Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):122-36. PubMed ID: 1626064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of benzene.
    Travis CC; Quillen JL; Arms AD
    Toxicol Appl Pharmacol; 1990 Mar; 102(3):400-20. PubMed ID: 2315912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.
    Kirman CR; Sweeney LM; Meek ME; Gargas ML
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):345-67. PubMed ID: 14623485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population toxicokinetics of benzene.
    Bois FY; Jackson ET; Pekari K; Smith MT
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1405-11. PubMed ID: 9118927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
    Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
    Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic parameters for interspecies scaling using allometric techniques.
    Hayton WL
    Health Phys; 1989; 57 Suppl 1():159-64. PubMed ID: 2606679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
    Sharma RP; Schuhmacher M; Kumar V
    Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models.
    Krewski D; Wang Y; Bartlett S; Krishnan K
    J Biopharm Stat; 1995 Nov; 5(3):245-71. PubMed ID: 8580927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in benzene disposition in male C57BL/6N mice described by a physiologically based pharmacokinetic model.
    McMahon TF; Medinsky MA; Birnbaum LS
    Toxicol Lett; 1994 Dec; 74(3):241-53. PubMed ID: 7871548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
    Cox LA
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): a computational method.
    Thomas RS; Lytle WE; Keefe TJ; Constan AA; Yang RS
    Fundam Appl Toxicol; 1996 May; 31(1):19-28. PubMed ID: 8998950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo.
    Cole CE; Tran HT; Schlosser PM
    J Toxicol Environ Health A; 2001 Mar; 62(6):439-65. PubMed ID: 11289318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and parameterization of pharmacokinetic models: their impact on model predictions.
    Woodruff TJ; Bois FY; Auslander D; Spear RC
    Risk Anal; 1992 Jun; 12(2):189-201. PubMed ID: 1502372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
    Mahmood I
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
    Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
    J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.